Boston Scientific’s Stroke Device Shows Mixed Results

Boston Scientific Corp.’s Watchman, designed to help prevent strokes in patients with an erratic heartbeat, may be a tougher sell for U.S. regulators after a study failed to confirm the device’s benefit.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.